PENTACYCLISCHE TRITERPENOID-VERBINDUNGEN ALS TOPOISOMERASE-INHIBITOREN ODER ZELL-DIFFERENZIERUNGS-INDUKTOREN

Pentacyclic triterpenoid compounds such as alpha -boswellic acid and its acetate, beta -boswellic acid and its acetate, which have an inhibitory effect on topoisomerase I and topoisomerase II, are disclosed. Compositions based on the pentacyclic triterpenoid compounds which can be used to treat vari...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LI, DE-HUA CHANG BAISHAN INSTITUTE OF MATERIA, TENG HUA JILIN, CN, FANG, QING INSTITUTE OF MATERIA MEDIC, 1 XIAN NONG TAN STREET BEIJING, CN, COOK, C., EDGAR RESEARCH TRIANGLE INSTITUTE, TRIANGLE PARK, NC 27709-2194, US, LEE, YUE-WEI RESEARCH TRIANGLE INSTITUTE, RESEARCH TRIANGLE PARK, NC 27709-2194, US, WANG, ZHEN-GUO CHANG BAISHAN INSTITUTE, SHENG-LI ROAD, TENG HUA JILIN, CN
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pentacyclic triterpenoid compounds such as alpha -boswellic acid and its acetate, beta -boswellic acid and its acetate, which have an inhibitory effect on topoisomerase I and topoisomerase II, are disclosed. Compositions based on the pentacyclic triterpenoid compounds which can be used to treat various cancers in mammals are also disclosed.